Seattle Genetics

Who’s on Biotech’s Endangered Species List? Mid-Sized Drugmakers
Xconomy
Mon, 05/21/12 - 12:55 pm
Regeneron
Illumina
Vivus
Seattle Genetics
Cubist Pharmaceuticals
Onyx
ASCO '12 Abstract Dump: Cancer Stocks in Focus
TheStreet.com
Thu, 05/17/12 - 10:35 am
ASCO
Array Biopharma
Exelixis
Pharmacyclics
Onyx
Seattle Genetics
Aveo
Ariad Pharmaceuticals
Arqule
Oncothyreon
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
6 Mid-Cap Biotechnology Stocks With Great Liquidity And Rated Buy Or Better
Seeking Alpha
Sun, 05/13/12 - 01:36 pm
Seattle Genetics
Biomarin
Jazz Pharmaceuticals
Illumina
Questcor Pharmaceuticals
Vivus
Seattle Genetics pares 1Q loss on Adcetris sales
Yahoo/AP
Tue, 05/8/12 - 07:20 pm
Seattle Genetics
earnings
It's Fashionably Late, but This Biotech's Party Is Just Starting
Motley Fool
Sat, 04/14/12 - 12:27 pm
Seattle Genetics
Adcetris
Hodgkin's lymphoma
anaplastic large-cell lymphoma
Dendreon May See Massive Gains By 2013 On Provenge
Seeking Alpha
Fri, 04/13/12 - 08:29 am
Dendreon
Provenge
JNJ
Medivation
prostate cancer
Immunogen
Seattle Genetics
7 Biotech Stocks Being Snapped Up By Insiders
Seeking Alpha
Sat, 03/17/12 - 10:46 am
Agenus
China Biologic
Halozyme
Incyte
NuPathe
QLT
Seattle Genetics
7 Cancer Drug Stocks to Know Right Now
Seeking Alpha
Wed, 03/14/12 - 10:54 am
Seattle Genetics
Celldex
Arqule
Daiichi Sankyo
JNJ
Medivation
Dendreon
Aveo Pharmaceutical
Ariad Pharmaceuticals
AstraZeneca
Array Biopharma
Oncothyreon
Seattle Genetics: A Cancer Niche Too Small
TheStreet.com
Mon, 03/5/12 - 11:11 am
Seattle Genetics
Adcetris
systemic anaplastic large cell lymphoma
Hodgkin's lymphoma
3 Biotech Takeover/LBO Potential Targets Being Snapped Up By Insiders
Seeking Alpha
Wed, 02/22/12 - 08:07 am
M&A
Seattle Genetics
Chelsea Therapeutics
Savient
3 Highly Shorted Biotech Stocks Being Bought Up By Hedge Funds
Seeking Alpha
Thu, 02/16/12 - 11:22 am
Vivus
Seattle Genetics
Amyris
Seattle Genetics Inc. Fourth Quarter Earnings Sneak Peek
Yahoo/Wall St Cheat Sheet
Wed, 02/8/12 - 03:14 pm
earnings
Seattle Genetics
Biotech Stocks To Watch In 2012
Seeking Alpha
Mon, 02/6/12 - 11:20 am
Astellas
Array Biopharma
AstraZeneca
Celldex
Exelixis
Pfizer
Progenics Pharmaceuticals
Seattle Genetics
Synta
Biotech Buyout Portfolio - Seattle Genetics
Seeking Alpha
Tue, 01/24/12 - 10:44 am
Seattle Genetics
Abbott Laboratories
Bristol-Myers Squibb
Pfizer
Seattle Genetics: Boxed Warning Is A Non-Event
Seeking Alpha
Sun, 01/22/12 - 12:32 pm
Seattle Genetics
progressive multifocal leukoencephalopathy
PML
Adcetris
Hodgkin's lymphoma
anaplastic large-cell lymphoma
Warning: Don't Sell on This News (Seattle Genetics)
Motley Fool
Sun, 01/15/12 - 01:36 pm
Seattle Genetics
progressive multifocal leukoencephalopathy
PML
Adcetris
Seattle Genetics Lymphoma Drug Gets Boxed Warning on Brain Infection Risk
Bloomberg
Sat, 01/14/12 - 11:25 am
Seattle Genetics
Adcetris
Hodgkin's lymphoma
progressive multifocal leukoencephalopathy
PML
Celldex Therapeutics: A Potential Triple With Data On The Way
Seeking Alpha
Wed, 01/11/12 - 10:58 am
Celldex
Amgen
Bristol-Myers Squibb
Dendreon
Seattle Genetics
Exelixis
Biotech Investors Buoyed By Signs Of Speedier Drug Launches
Seeking Alpha
Mon, 01/9/12 - 10:40 am
drug launches
Dendreon
Incyte
Human Genome Sciences
Regeneron
Seattle Genetics
Vertex

Pages